Activated PI3K Delta Syndrome (APDS) Latest Advances
Find the Latest Research About Activated PI3K Delta Syndrome (APDS)
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 114 publications
Allergic airway reactions rewired by PI3Kδ mutation.
Journal: The Journal of experimental medicine
Published: February 20, 2026
Diagnostic odyssey of patients with the rare immunodeficiency activated PI3 kinase delta syndrome (APDS): case study from expert and patient surveys.
Journal: Frontiers in immunology
Published: December 08, 2025
Phosphoinositide 3-kinase δ activity in patients with systemic lupus erythematosus.
Journal: Frontiers in immunology
Published: November 13, 2025
Evaluating the impact of leniolisib treatment on symptoms and health-related quality of life in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome.
Journal: Frontiers in immunology
Published: November 04, 2025
Activated PI3Kδ syndrome in inborn errors of immunity: diagnostic strategies and clinical challenges.
Journal: Frontiers in immunology
Published: October 29, 2025
Activated PIK3CD drives marginal zone B cell development from early transitional progenitors by enhancing ADAM10 expression.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: October 15, 2025
A rare case report of activated PI3K delta syndrome (APDS): diagnostic pitfalls.
Journal: BMC pediatrics
Published: July 31, 2025
Real-World Health Care Resource Utilization and Costs Among Patients with Activated Phosphoinositide 3-Kinase Delta (PI3Kδ) Syndrome in the United States.
Journal: Advances in therapy
Published: July 18, 2025
Loss of B cell tolerance at the T2/T3a B cell transition is a convergent pathogenic mechanism in common variable immunodeficiency.
Journal: bioRxiv : the preprint server for biology
Published: July 15, 2025
Recurrent Macular Vasculitis in Hypergammaglobulinemia as an Underrecognized Presenting Manifestation of Activated PI3K Delta Syndrome.
Journal: Pediatric dermatology
Published: July 13, 2025
Natural history of clinical manifestations in activated phosphoinositide 3-kinase δ syndrome (APDS): Time-to-event analyses using the European Society for Immunodeficiencies-APDS registry.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 04, 2025
Key outcomes in treatment of activated phosphoinositide 3-kinase delta syndrome: An e-Delphi panel study and responder threshold application.
Journal: PloS one
Published: June 26, 2025
Last Updated: 06/30/2026